About this trial
Pediatric kidney transplant recipients often face major psychosocial challenges that are difficult to address with existing tools. This study evaluates whether clinically supervised AI can generate personalized, age-adapted therapeutic stories for these children and their families.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 5-12 years inclusive at enrolment.
Recipient of a kidney transplant.
Clinically stable at enrolment (no active rejection, acute infection, or current hospitalization for a graft-related complication).
Fluency in French or English.
Disqualifiers
Severe cognitive impairment precluding engagement with narrative content.
Mental state not allowing participation.
Family unwilling or unable to commit to the study timeline and interview requirements.
Trial population
Pediatric kidney recipients
Trial design
Cohort
Prospective
Treatments tested in this trial
AI-generated story
Other interventionA story generated by artificial intelligence is created and personalized for pediatric kidney recipient
AI generated story
Other interventionThis is a minimal-risk observational study. Families complete a questionnaire and receive an AI-generated, clinically supervised personalized story. During the pilot phase, there is no direct child-AI interaction. All stories are reviewed by the clinical lead before delivery.
Treatment groups
Trial outcomes
Primary outcomes
Child and family experience of the story after delivery.
Child and family experience of the story, assessed through qualitative feedback, thematic analysis, and satisfaction ratings collected after story delivery.
Child and family experience of the story after delivery.
Child and family experience of the story, assessed through qualitative feedback, thematic analysis, and satisfaction ratings collected after story delivery.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.